Ocular Therapeutix, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -7.4% | -7.4% | -3.2% |
| FY2022 | -200.8% | -200.8% | -47.6% |
| FY2023 | -88.6% | -88.6% | -32.0% |
| FY2024 | -61.4% | -61.4% | -42.3% |
| FY2025 | -40.6% | -40.6% | -32.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -7.4% | -7.4% | -3.2% |
| FY2022 | -200.8% | -200.8% | -47.6% |
| FY2023 | -88.6% | -88.6% | -32.0% |
| FY2024 | -61.4% | -61.4% | -42.3% |
| FY2025 | -40.6% | -40.6% | -32.9% |